Related Experiment Videos
[Angioimmunoblastic lymphadenopathy and colonic lymphoma]
D Bagilet1, M Diab, R Aristiquí
1Servicio de Clínica Médica, Sanatorio Delta, Rosario, Argentina.
Medicina
|January 1, 1990
Summary
Angioimmunoblastic lymphadenopathy (AILD) can lead to severe immune disorders and an increased risk of developing cancers. This case highlights how AILD and corticosteroid treatment may contribute to extranodal lymphoma development.
Area of Science:
- Immunology
- Oncology
- Pathology
Background:
- Angioimmunoblastic lymphadenopathy (AILD) is a rare, often fatal T-cell lymphoproliferative disorder.
- AILD is characterized by lymphadenopathy, hepatosplenomegaly, fever, rash, and immune dysregulation.
- While not initially considered malignant, AILD can predispose patients to infections and secondary malignancies.